A major breakthrough published by Professor Jacques Fantini’s team
AmyPore is proud to announce that the team of Professor Jacques Fantini, co-inventor with Professor Nouara Yahi of the AmyP53 solution, has just published a
15 March 2025
AmyPore is proud to announce that the team of Professor Jacques Fantini, co-inventor with Professor Nouara Yahi of the AmyP53 solution, has just published a
AmyPore is proud to announce that the company has been selected to represent startups from the Région Sud in France in the Health category at
AmyPore is working on an innovative therapeutic solution for patients and caregivers: the AmyP53 therapeutic peptide for the treatment of Alzheimer’s and Parkinson’s diseases. This would
AD/PD 2024 Advances in Science & Therapy International Conference of Alzheimer’s and Parkinson’s diseases and related neurological disorders March 5-9, 2024 – Lisbon, Portugal Our
